Subgroup Analysis By Ki-67 And Primary Tumour Origins Of The Randomized, Placebo-Controlled Phase Iii Study Of Surufatinib In Advanced Well-Differentiated Extrapancreatic Neuroendocrine Tumours (Sanet-Ep)
ANNALS OF ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要